Liver metastases and immunotherapy: A barrier to response for metastatic melanoma

J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e186-e188. doi: 10.1111/jdv.18590. Epub 2022 Oct 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunotherapy
  • Liver Neoplasms* / secondary
  • Liver Neoplasms* / therapy
  • Melanoma* / pathology
  • Nivolumab

Substances

  • Nivolumab